Schenk Chris 4
4 · Ategrity Specialty Insurance Co Holdings · Filed May 7, 2026
Research Summary
AI-generated summary of this filing
Ategrity (ASIC) President Chris Schenk Receives 21,981-Share Award
What Happened
- Chris Schenk, President and Chief Underwriting Officer of Ategrity Specialty Insurance Co Holdings (ASIC), acquired 21,981 shares on March 5, 2026. The filing reports the shares as a derivative award (code A) at $0.00 per share — this reflects vesting of a previously granted option rather than an open-market purchase or sale. No sale of the shares was reported in the Form 4.
Key Details
- Transaction date: 2026-03-05; Form 4 filed: 2026-05-07.
- Reported transaction: 21,981 shares acquired at $0.00 (derivative award/vesting).
- Footnote: On Jan 1, 2022 Schenk was granted an option for 43,963 shares; 50% (21,981 shares) became eligible to vest as of Jan 1, 2026 after Ategrity met performance criteria for fiscal years 2024–2025, triggering this vesting.
- Shares owned after the transaction: not specified in the filing.
- Timeliness: The Form 4 was filed about two months after the March 5 transaction, which appears late relative to the SEC’s two-business-day filing requirement.
Context
- This was a vesting of a previously awarded option (derivative award), not an open-market purchase or sale. Such vesting reports reflect compensation or incentive plan payouts and are not direct indications of buying or selling intent.
Insider Transaction Report
Form 4
Schenk Chris
See Remarks
Transactions
- Award
Stock Option (right to buy)
[F1]2026-03-05+21,981→ 21,981 totalExercise: $10.66From: 2026-03-05Exp: 2032-01-01→ Common Stock (21,981 underlying)
Footnotes (1)
- [F1]On January 1, 2022 the reporting person was granted an option to purchase 43,963 shares of common stock. 50% of the option was eligible to vest as of January 1, 2026 based on the Issuer's satisfaction of certain performance criteria for the two fiscal years immediately preceding the vesting date. The performance criteria for 2024 and 2025 were met, resulting in the vesting of the option as to 21,981 shares.
Signature
/s/ Eric Crespolini, Attorney-in-Fact|2026-05-07